147 related articles for article (PubMed ID: 9174872)
1. Left ventricular and microvascular hypertrophy in essential hypertension: clinical relevance and prognostic implications.
Thürmann PA
Int J Clin Pharmacol Ther; 1997 May; 35(5):181-7. PubMed ID: 9174872
[TBL] [Abstract][Full Text] [Related]
2. [Antihypertensive treatment and left ventricular hypertrophy].
Agabiti-Rosei E; Muiesan ML; Rizzoni D
Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
4. [Left ventricular remodeling in arterial hypertension and its therapy].
Dúbrava J
Vnitr Lek; 1998 Jan; 44(1):50-6. PubMed ID: 9750485
[TBL] [Abstract][Full Text] [Related]
5. [Impact of arterial hypertension on the heart].
Herpin D
Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
[TBL] [Abstract][Full Text] [Related]
6. [The organ damage in arterial hypertension].
Agabiti-Rosei E; Muiesan ML
Ann Ital Med Int; 1995 Oct; 10 Suppl():99S-107S. PubMed ID: 8562278
[TBL] [Abstract][Full Text] [Related]
7. Regression of left ventricular hypertrophy in patients with hypertension.
Balogun MO; Dunn FG
J Hum Hypertens; 1990 Oct; 4 Suppl 4():29-32; discussion 32-4. PubMed ID: 2149391
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
9. [The primary and secondary prevention of hypertensive cardiopathy].
Agabiti-Rosei E; Muiesan ML
Ital Heart J; 2000 Jun; 1 Suppl 2():59-66. PubMed ID: 10905130
[TBL] [Abstract][Full Text] [Related]
10. [Regression of left ventricular hypertrophy in hypertensive patients].
Bosa Ojeda F; García González M; Domínguez Rodríguez A; Barragán Acea A; Miralles Ibarra JM; Lacalzada Almeida J; de Armas Trujillo D
Rev Esp Cardiol; 1997; 50 Suppl 4():74-6. PubMed ID: 9411592
[TBL] [Abstract][Full Text] [Related]
11. Reversal of left ventricular hypertrophy: a desirable therapeutic goal?
Schmieder RE; Messerli FH
J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S16-22. PubMed ID: 1707110
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence?
Wang AY; Li PK; Lui SF; Sanderson JE
Nephrology (Carlton); 2004 Aug; 9(4):190-7. PubMed ID: 15363049
[TBL] [Abstract][Full Text] [Related]
13. Cardiac hypertrophy and hypertension.
Dunn FG
Blood Press Suppl; 1995; 2():17-21. PubMed ID: 7582068
[TBL] [Abstract][Full Text] [Related]
14. [Relation between cardiac hypertrophy and changes in the large arterial trunks. Role of the renin-angiotensin system].
Benetos A
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():21-4. PubMed ID: 7646306
[TBL] [Abstract][Full Text] [Related]
15. [Myocardial fibrosis--the theoretical bases, clinical aspects and therapeutic implications].
Perdigão C
Rev Port Cardiol; 1993; 12(7-8):675-85, 603. PubMed ID: 8352988
[TBL] [Abstract][Full Text] [Related]
16. Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy.
Frohlich ED; González A; Díez J
J Hypertens; 2011 Jan; 29(1):17-26. PubMed ID: 21045723
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular hypertrophy and hypertension: causes and consequences.
Korner PI
Blood Press Suppl; 1995; 2():6-16. PubMed ID: 7582077
[TBL] [Abstract][Full Text] [Related]
20. Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness.
Lekakis JP; Zakopoulos NA; Protogerou AD; Kotsis VT; Papaioannou TG; Stamatelopoulos KS; Tsitsiricos MD; Pitiriga VCh; Papamichael CM; Toumanides ST; Mavrikakis ME
Int J Cardiol; 2004 Oct; 97(1):29-33. PubMed ID: 15336803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
